1. Home
  2. EBS vs BEAG Comparison

EBS vs BEAG Comparison

Compare EBS & BEAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • BEAG
  • Stock Information
  • Founded
  • EBS 1998
  • BEAG 2021
  • Country
  • EBS United States
  • BEAG United States
  • Employees
  • EBS 900
  • BEAG N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • BEAG
  • Sector
  • EBS Health Care
  • BEAG
  • Exchange
  • EBS Nasdaq
  • BEAG NYSE
  • Market Cap
  • EBS 353.9M
  • BEAG 326.6M
  • IPO Year
  • EBS 2006
  • BEAG 2024
  • Fundamental
  • Price
  • EBS $6.39
  • BEAG $10.45
  • Analyst Decision
  • EBS Strong Buy
  • BEAG
  • Analyst Count
  • EBS 3
  • BEAG 0
  • Target Price
  • EBS $14.33
  • BEAG N/A
  • AVG Volume (30 Days)
  • EBS 1.3M
  • BEAG 175.7K
  • Earning Date
  • EBS 08-05-2025
  • BEAG 01-01-0001
  • Dividend Yield
  • EBS N/A
  • BEAG N/A
  • EPS Growth
  • EBS N/A
  • BEAG 221.31
  • EPS
  • EBS N/A
  • BEAG 0.28
  • Revenue
  • EBS $965,400,000.00
  • BEAG N/A
  • Revenue This Year
  • EBS N/A
  • BEAG N/A
  • Revenue Next Year
  • EBS $18.88
  • BEAG N/A
  • P/E Ratio
  • EBS N/A
  • BEAG $37.40
  • Revenue Growth
  • EBS N/A
  • BEAG N/A
  • 52 Week Low
  • EBS $4.02
  • BEAG $9.84
  • 52 Week High
  • EBS $15.10
  • BEAG $11.20
  • Technical
  • Relative Strength Index (RSI)
  • EBS 60.32
  • BEAG N/A
  • Support Level
  • EBS $6.53
  • BEAG N/A
  • Resistance Level
  • EBS $6.98
  • BEAG N/A
  • Average True Range (ATR)
  • EBS 0.35
  • BEAG 0.00
  • MACD
  • EBS 0.01
  • BEAG 0.00
  • Stochastic Oscillator
  • EBS 84.04
  • BEAG 0.00

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About BEAG BOLD EAGLE ACQUISITION CORP

Bold Eagle Acquisition Corp is a blank check company.

Share on Social Networks: